ArticleDiabetes/metabolism research and reviews2025

Long-Term Glucagon-Like Peptide 1 Receptor Agonist Use Is Not Associated With Increased Risk of Thyroid Cancer in Adults With Type 2 Diabetes.

Rena Pollack et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.